FindTrial
Sign In

The relationship between diabetic medications, blood sugar control, and the risk of dementia in people with type 2 Diabetes

The rapport between anti diabetic medications,glycemic control in conjunction with risk of dementia in patients with Type II Diabetes Mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075532
Enrollment
138
Registered
2024-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: NIL: NIL

Sponsors

NITTE(Deemed to be university),NGSM Institute of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are diagnosed with type-2 diabetes and are on antidiabetic medication Age above 18 years Gender - male and female Stable diabetic patients

Exclusion criteria

Exclusion criteria: Patients with known case of dementia. Breast feeding and pregnant women Patients diagnosed with type 1 diabetes Patients who are already on dementia medications. Patients on Vit B12 supplements.

Design outcomes

Primary

MeasureTime frame
The study will determine risk of dementia in the age groups greater than 18 years of type 2 diabetic patientsTimepoint: single point—

Secondary

MeasureTime frame
The study will analyse the relationship between anti-diabetic medication and glycaemic control with risk of dementia in type 2 DM.Timepoint: Single point.—

Countries

India

Contacts

Public ContactDr Uday Venkat Mateti

NGSM Institute of Pharmaceutical sciences

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026